← Back to Search

Behavioral Intervention

Meditative Neurofeedback for Depression (MediNF Trial)

N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test a meditation-based treatment for people with depression in an open and transparent way.

Who is the study for?
This trial is for individuals with moderate depression as measured by the PHQ9, a common symptom rating tool. It's not suitable for those who are acutely suicidal, currently abusing substances, or diagnosed with psychotic disorders or bipolar disorder.
What is being tested?
The study is testing MediNF, a meditative neurofeedback intervention designed to improve mood in people suffering from depression. This open-label single-arm study means all participants receive the same treatment without a comparison group.
What are the potential side effects?
Since this trial involves meditative practices and biofeedback rather than medication, side effects may include discomfort during sessions or frustration if no improvement in mood is perceived.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PHQ9
Secondary study objectives
GAD7
MAAS
RRQ

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MediNFExperimental Treatment1 Intervention
Over 10-sessions participants will engage in a breath-focused meditative practice with frontal brain connectivity neurofeedback provided to enhance performance.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,180 Previous Clinical Trials
1,575,020 Total Patients Enrolled
37 Trials studying Depression
59,445 Patients Enrolled for Depression
~18 spots leftby Nov 2025